Cargando…

Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy

A highly oxidized form of a chitosan/dextran-based hydrogel (CD-100) containing 80% oxidized dextran aldehyde (DA-100) was developed as a post-operative aid, and found to significantly prevent adhesion formation in endoscopic sinus surgery (ESS). However, the CD-100 hydrogel showed moderate in vitro...

Descripción completa

Detalles Bibliográficos
Autores principales: Chan, Maggie, Brooks, Heather J. L., Moratti, Stephen C., Hanton, Lyall R., Cabral, Jaydee D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490524/
https://www.ncbi.nlm.nih.gov/pubmed/26086827
http://dx.doi.org/10.3390/ijms160613798
_version_ 1782379523157786624
author Chan, Maggie
Brooks, Heather J. L.
Moratti, Stephen C.
Hanton, Lyall R.
Cabral, Jaydee D.
author_facet Chan, Maggie
Brooks, Heather J. L.
Moratti, Stephen C.
Hanton, Lyall R.
Cabral, Jaydee D.
author_sort Chan, Maggie
collection PubMed
description A highly oxidized form of a chitosan/dextran-based hydrogel (CD-100) containing 80% oxidized dextran aldehyde (DA-100) was developed as a post-operative aid, and found to significantly prevent adhesion formation in endoscopic sinus surgery (ESS). However, the CD-100 hydrogel showed moderate in vitro cytotoxicity to mammalian cell lines, with the DA-100 found to be the cytotoxic component. In order to extend the use of the hydrogel to abdominal surgeries, reformulation using a lower oxidized DA (DA-25) was pursued. The aim of the present study was to compare the antimicrobial efficacy, in vitro biocompatibility and wound healing capacity of the highly oxidized CD-100 hydrogel with the CD-25 hydrogel. Antimicrobial studies were performed against a range of clinically relevant abdominal microorganisms using the micro-broth dilution method. Biocompatibility testing using human dermal fibroblasts was assessed via a tetrazolium reduction assay (MTT) and a wound healing model. In contrast to the original DA-100 formulation, DA-25 was found to be non-cytotoxic, and showed no overall impairment of cell migration, with wound closure occurring at 72 h. However, the lower oxidation level negatively affected the antimicrobial efficacy of the hydrogel (CD-25). Although the CD-25 hydrogel’s antimicrobial efficacy and anti-fibroblast activity is decreased when compared to the original CD-100 hydrogel formulation, previous in vivo studies show that the CD-25 hydrogel remains an effective, biocompatible barrier agent in the prevention of postoperative adhesions.
format Online
Article
Text
id pubmed-4490524
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-44905242015-07-07 Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy Chan, Maggie Brooks, Heather J. L. Moratti, Stephen C. Hanton, Lyall R. Cabral, Jaydee D. Int J Mol Sci Article A highly oxidized form of a chitosan/dextran-based hydrogel (CD-100) containing 80% oxidized dextran aldehyde (DA-100) was developed as a post-operative aid, and found to significantly prevent adhesion formation in endoscopic sinus surgery (ESS). However, the CD-100 hydrogel showed moderate in vitro cytotoxicity to mammalian cell lines, with the DA-100 found to be the cytotoxic component. In order to extend the use of the hydrogel to abdominal surgeries, reformulation using a lower oxidized DA (DA-25) was pursued. The aim of the present study was to compare the antimicrobial efficacy, in vitro biocompatibility and wound healing capacity of the highly oxidized CD-100 hydrogel with the CD-25 hydrogel. Antimicrobial studies were performed against a range of clinically relevant abdominal microorganisms using the micro-broth dilution method. Biocompatibility testing using human dermal fibroblasts was assessed via a tetrazolium reduction assay (MTT) and a wound healing model. In contrast to the original DA-100 formulation, DA-25 was found to be non-cytotoxic, and showed no overall impairment of cell migration, with wound closure occurring at 72 h. However, the lower oxidation level negatively affected the antimicrobial efficacy of the hydrogel (CD-25). Although the CD-25 hydrogel’s antimicrobial efficacy and anti-fibroblast activity is decreased when compared to the original CD-100 hydrogel formulation, previous in vivo studies show that the CD-25 hydrogel remains an effective, biocompatible barrier agent in the prevention of postoperative adhesions. MDPI 2015-06-16 /pmc/articles/PMC4490524/ /pubmed/26086827 http://dx.doi.org/10.3390/ijms160613798 Text en © 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chan, Maggie
Brooks, Heather J. L.
Moratti, Stephen C.
Hanton, Lyall R.
Cabral, Jaydee D.
Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy
title Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy
title_full Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy
title_fullStr Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy
title_full_unstemmed Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy
title_short Reducing the Oxidation Level of Dextran Aldehyde in a Chitosan/Dextran-Based Surgical Hydrogel Increases Biocompatibility and Decreases Antimicrobial Efficacy
title_sort reducing the oxidation level of dextran aldehyde in a chitosan/dextran-based surgical hydrogel increases biocompatibility and decreases antimicrobial efficacy
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4490524/
https://www.ncbi.nlm.nih.gov/pubmed/26086827
http://dx.doi.org/10.3390/ijms160613798
work_keys_str_mv AT chanmaggie reducingtheoxidationlevelofdextranaldehydeinachitosandextranbasedsurgicalhydrogelincreasesbiocompatibilityanddecreasesantimicrobialefficacy
AT brooksheatherjl reducingtheoxidationlevelofdextranaldehydeinachitosandextranbasedsurgicalhydrogelincreasesbiocompatibilityanddecreasesantimicrobialefficacy
AT morattistephenc reducingtheoxidationlevelofdextranaldehydeinachitosandextranbasedsurgicalhydrogelincreasesbiocompatibilityanddecreasesantimicrobialefficacy
AT hantonlyallr reducingtheoxidationlevelofdextranaldehydeinachitosandextranbasedsurgicalhydrogelincreasesbiocompatibilityanddecreasesantimicrobialefficacy
AT cabraljaydeed reducingtheoxidationlevelofdextranaldehydeinachitosandextranbasedsurgicalhydrogelincreasesbiocompatibilityanddecreasesantimicrobialefficacy